about
Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activa...
Read More
8.33
0.48
(6.11%)
1.3M
XNAS Volume
XNAS 21 Sep, 2026 4:12 PM (EDT)
Not Eligible
Mid Valuation
Technically Moderately Bullish
Agenus Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..